Cargando…
COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection
In March 2020, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 was declared a global pandemic by the World Health Organization (WHO). The clinical course of the disease is unpredictable but may lead to severe acute respiratory infection (SARI) and pneumonia leading to acute respiratory dist...
Autores principales: | Kotfis, Katarzyna, Lechowicz, Kacper, Drożdżal, Sylwester, Niedźwiedzka-Rystwej, Paulina, Wojdacz, Tomasz K., Grywalska, Ewelina, Biernawska, Jowita, Wiśniewska, Magda, Parczewski, Miłosz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830835/ https://www.ncbi.nlm.nih.gov/pubmed/33477294 http://dx.doi.org/10.3390/ph14010071 |
Ejemplares similares
-
COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection
por: Lechowicz, Kacper, et al.
Publicado: (2020) -
Mineralocorticoid Receptor Antagonist (Potassium Canrenoate) Does Not Influence Outcome in the Treatment of COVID-19-Associated Pneumonia and Fibrosis—A Randomized Placebo Controlled Clinical Trial
por: Kotfis, Katarzyna, et al.
Publicado: (2022) -
Interplay between Neutrophils, NETs and T-Cells in SARS-CoV-2 Infection—A Missing Piece of the Puzzle in the COVID-19 Pathogenesis?
por: Niedźwiedzka-Rystwej, Paulina, et al.
Publicado: (2021) -
The Effect of Potassium Canrenoate (Mineralocorticoid Receptor Antagonist) on the Markers of Inflammation in the Treatment of COVID-19 Pneumonia and Fibrosis—A Secondary Analysis of Randomized Placebo-Controlled Clinical Trial
por: Karolak, Igor, et al.
Publicado: (2023) -
Cardiac Delirium Index for Predicting the Occurrence of Postoperative Delirium in Adult Patients After Coronary Artery Bypass Grafting
por: Lechowicz, Kacper, et al.
Publicado: (2021)